METTL14 and neoplasm: We come to a conclusion that the proposed modulatory model of IGF2BP3 in CC, in which IGF2BP3 regulates the methylation of SCD mRNA by IGF2BP3-METTL14 complex, thereby accelerating lipid metabolism and tumor progression in CC (Fig. 6H).